Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18614783.
- Also identified by DOI 10.1056/NEJMoa0706300 and PMC identifier 2518320.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atrial fibrillation is a common arrhythmia that is hereditary in a small subgroup of patients. In a family with 11 clinically affected members, we mapped an atrial fibrillation locus to chromosome 1p36-p35 and identified a heterozygous frameshift mutation in the gene encoding atrial natriuretic peptide. Circulating chimeric atrial natriuretic peptide (ANP) was detected in high concentration in subjects with the mutation, and shortened atrial action potentials were seen in an isolated heart model, creating a possible substrate for atrial fibrillation. This report implicates perturbation of the atrial natriuretic peptide-cyclic guanosine monophosphate (cGMP) pathway in cardiac electrical instability.
Medical subject headings
- Atrial Fibrillation
- Atrial Natriuretic Factor
- Frameshift Mutation